Barclays maintains Mueller Water Products at Underweight, lowers price target to $24 from $25

Barclays downgraded Mueller Water Products to Underweight, lowering its price target from $25 to $24, a 4% decrease. This implies a 2.6% downside from the Nov 5 close of $24.63, according to the bank.

Original reporting
Published Nov 6, 2026, 4:20 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 6, 2026, 4:29 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Barclays maintains Mueller Water Products at Underweight, lowers price target to $24 from $25 — source image
Decision brief

The 30-second read

Med
01

Why it matters

Analyst target revisions can shift investor expectations and trigger short-term price moves.

02

Market read

A modest analyst downgrade that may prompt short-term selling pressure on MWPP.

03

What to watch

Recent contract wins or operational improvements not reflected in the downgrade.

Relevance 7/10Novelty 6/10Timing: today

Background

Barclays' analyst team issued a new rating and price target for Mueller Water Products.

Market effects

May weigh on the water infrastructure sector as peers could face similar analyst scrutiny.

Limited to U.S. industrial equities.

Low global relevance; impact confined to U.S. markets.

Counterpoint

The target cut could be an overreaction; the stock may be undervalued relative to peers.

Key entities

  • Mueller Water Products

    U.S. manufacturer of water infrastructure products.

  • Barclays

    Investment bank providing the price target revision.

Related articles

$XYLMed

A look back at water infrastructure stocks’ Q3 earnings: Xylem (NYSE:XYL) vs the rest of the pack

Xylem (NYSE:XYL) and four other water infrastructure stocks reported Q3 earnings. Xylem missed revenue estimates by 3.5% with a 3% YoY decline, while Watts Water (NYSE:WTS) beat estimates by 5.2% with 19% YoY growth. The sector saw a 6.2% revenue miss overall and a 2.6% average stock decline post-earnings. Xylem's stock fell 9.6%, while Watts Water traded sideways, and Mueller Water (NYSE:MWA) rose 1.4%.

$MWAHighAI 8/10

What Mueller Water Products (MWA) Said on Its Q4 Earnings Call

Mueller Water Products (MWA) reported Q4 net sales of $376.5M, down 1.1% YoY, with adjusted EBITDA up 4.0% to $95.5M. The company expects an annualized EBITDA margin benefit of 100-140 basis points from Q2. For 2027, MWA forecasts net sales of $1.44B-$1.47B and adjusted EBITDA of $378M-$388M, with a midpoint EBITDA margin of 26.3%. Free cash flow was $207.3M in 2026, and the company increased its repurchase authorization by $300M and raised its dividend by 14.3%.

$MWAMed

Mueller Water Products Inc (MWA) (Q4 2026) Earnings Call Highlights: Record Full-Year

Mueller Water Products (MWA) reported record full-year results for 2026. CEO Paul McAndrew announced the transition of the metering business to Zena USA, expecting an annualized adjusted EBITDA margin benefit of 100-140 basis points (about $8 million) starting in Q2 2027, with $26 million in one-time expenses in 2027. The company guided to an 110 basis point adjusted EBITDA margin expansion for 2027, driven by portfolio optimization, higher pricing, and operational improvements.

$MWAHighAI 8/10

Mueller Water (MWA) Q4 2026 Earnings Call Transcript

Mueller Water (MWA) reported Q4 2026 earnings with $207M in free cash flow, returning $74M to shareholders. The company increased its share repurchase authorization by $300M and raised its quarterly dividend by 14.3%. Mueller also announced plans to transition its metering business to Zenner USA, expecting $26M in one-time expenses and a 100-140 basis point EBITDA margin expansion. Q4 net sales decreased 1.1% YoY, but gross margin expanded 20 basis points.

$MWAMedAI 8/10

Mueller Water Q4FY26 Results: EBITDA up 14.1%, exits metering unit

Mueller Water Products reported Q4FY26 adjusted EBITDA up 14.1% to $372M, with full-year sales rising 3.2% to $1.5B. The company exited its metering unit, expecting $8M annualized EBITDA benefit. FY27 guidance: sales $1.44B-$1.47B (below consensus), EBITDA $378M-$388M. The company increased share buyback authorization by $300M and raised its dividend by 14.3%.